Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹270 Cr₹293 Cr₹241 Cr₹336 Cr₹279 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹270 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹270 Cr
Mar2025₹293 Cr
Mar2024₹241 Cr
Mar2023₹336 Cr
Mar2022₹279 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹270 Cr
-7.65
Mar2025 ₹293 Cr
21.25
Mar2024 ₹241 Cr
-28.28
Mar2023 ₹336 Cr
20.42
Mar2022 ₹279 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹123.3 Cr 10.3% 1.1% -49% Stock Analytics
ADANI ENTERPRISES ₹369,580.0 Cr 5.4% 5.2% 14.2% Stock Analytics
ADITYA INFOTECH ₹51,697.1 Cr 8.8% 6.1% 211.5% Stock Analytics
AEGIS LOGISTICS ₹41,256.5 Cr -0.4% -15% 48.4% Stock Analytics
PREMIER ENERGIES ₹40,174.7 Cr -0.4% -0.1% -16.6% Stock Analytics
REDINGTON ₹26,330.2 Cr 0.4% -13.2% 29.5% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

10.3%

1.1%

-49%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses